Cargando…

Prostate Health Index and Prostate Health Index Density as Diagnostic Tools for Improved Prostate Cancer Detection

BACKGROUND: To evaluate the diagnostic potential of [-2] proPSA (p2PSA), %p2PSA, Prostate Health Index (phi), and phi density (PHID) as independent biomarkers and in composition of multivariable models in predicting high-grade prostatic intraepithelial neoplasia (HGPIN) and overall and clinically si...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barisiene, Marija, Bakavicius, Arnas, Stanciute, Diana, Jurkeviciene, Jolita, Zelvys, Arunas, Ulys, Albertas, Vitkus, Dalius, Jankevicius, Feliksas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396080/ https://www.ncbi.nlm.nih.gov/pubmed/32775459 http://dx.doi.org/10.1155/2020/9872146

Ejemplares similares

Urinary DNA methylation biomarkers for prediction of prostate cancer upgrading and upstaging
por: Bakavicius, Arnas, et al.
Publicado: (2019)

The Impact of Prostate Cancer Upgrading and Upstaging on Biochemical Recurrence and Cancer-Specific Survival
por: Bakavičius, Arnas, et al.
Publicado: (2020)

Promoter Methylation of PRKCB, ADAMTS12, and NAALAD2 Is Specific to Prostate Cancer and Predicts Biochemical Disease Recurrence
por: Daniunaite, Kristina, et al.
Publicado: (2021)

Complications after male adjustable suburethral sling implantation
por: Cerniauskiene, Ausra, et al.
Publicado: (2020)

Urinary DNA as a Tool for Germline and Somatic Mutation Detection in Castration-Resistant Prostate Cancer Patients
por: Januskevicius, Tomas, et al.
Publicado: (2023)

Clinical Significance of ADAMTS19, BMP7, SIM1, and SFRP1 Promoter Methylation in Renal Clear Cell Carcinoma
por: Kubiliute, Raimonda, et al.
Publicado: (2021)

Evaluation of Renal Function after Partial Nephrectomy and Detection of Clinically Significant Acute Kidney Injury
por: Makevičius, Jurijus, et al.
Publicado: (2022)

The utility of urine-circulating miRNAs for detection of prostate cancer
por: Stuopelyte, Kristina, et al.
Publicado: (2016)

Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy
por: Vėželis, Alvydas, et al.
Publicado: (2021)

LMTK2 as Potential Biomarker for Stratification between Clinically Insignificant and Clinically Significant Prostate Cancer
por: Vezelis, Alvydas, et al.
Publicado: (2021)

Safety, Pharmacokinetic and Pharmacodynamic Evaluation of Teverelix for the Treatment of Hormone-Sensitive Advanced Prostate Cancer: Phase 2 Loading-Dose-Finding Studies
por: MacLean, Carol M., et al.
Publicado: (2023)

Factors influencing extracorporeal shock wave lithotripsy efficiency for optimal patient selection
por: Snicorius, Marius, et al.
Publicado: (2021)

Malignant mixed epithelial and stromal tumour of the kidney: a case report and a literature review
por: Bakavičius, Arnas, et al.
Publicado: (2018)

Decreased expression of MT1E is a potential biomarker of prostate cancer progression
por: Demidenko, Rita, et al.
Publicado: (2017)

Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients
por: Bosas, Paulius, et al.
Publicado: (2021)

Prostate Health Index Density Outperforms Prostate Health Index in Clinically Significant Prostate Cancer Detection
por: Chiu, Shih-Ting, et al.
Publicado: (2021)

Treatment of recurrent stress urinary incontinence in women: comparison of treatment results for different surgical techniques
por: Cerniauskiene, Ausra, et al.
Publicado: (2014)

Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer
por: Boo, Youngjun, et al.
Publicado: (2023)

Incidentally Found Prostate Cancer and Influence on Overall Survival after Radical Cystoprostatectomy
por: Sruogis, Algimantas, et al.
Publicado: (2012)

Comparisons of the diagnostic accuracy across prostate health index, prostate health index density, and percentage free prostate-specific antigen for clinically significant prostate cancer: a prospective diagnostic study
por: Wu, Bo, et al.
Publicado: (2023)

Letter to the Editor: No immunophenotyping in peripheral blood of prostate cancer patients treated with neoadjuvant Rituximab?
por: Bosas, Paulius, et al.
Publicado: (2020)

Prostate cancer solitary metastasis to anal canal: case report and review of literature
por: Dulskas, Audrius, et al.
Publicado: (2019)

Frequent down-regulation of ABC transporter genes in prostate cancer
por: Demidenko, Rita, et al.
Publicado: (2015)

Assessment on clinical value of prostate health index in the diagnosis of prostate cancer
por: Zhang, Guangying, et al.
Publicado: (2019)

Prostate health index is useful for prostate cancer detecting in Chinese people
por: Huang, Yuhua, et al.
Publicado: (2019)

Modified Prostate Health Index Density Significantly Improves Clinically Significant Prostate Cancer (csPCa) Detection
por: Chen, Haojie, et al.
Publicado: (2022)

Utility of Prostate-Specific Antigen Isoforms and Prostate Health Index in the Diagnosis of Metastatic Prostate Cancer
por: Raju, Govinda Nanjaiah Laxmana, et al.
Publicado: (2022)

A prospective study of the prostate health index density and multiparametric magnetic resonance imaging in diagnosing clinically significant prostate cancer
por: Chen, Yuanchong, et al.
Publicado: (2023)

Cost-Effectiveness Analysis of Prostate Health Index in Decision Making for Initial Prostate Biopsy
por: Huang, Da, et al.
Publicado: (2020)

The Prostate Health Index aids multi-parametric MRI in diagnosing significant prostate cancer
por: Fan, Yu-Hua, et al.
Publicado: (2021)

Beyond PSA: The Role of Prostate Health Index (phi)
por: Ferro, Matteo, et al.
Publicado: (2020)

Performance of prostate health index and PSA density in a diverse biopsy‐naïve cohort with mpMRI for detecting significant prostate cancer
por: Carbunaru, Samuel, et al.
Publicado: (2021)

Malakoplakia of the Prostate as a Mimicker of Prostate Cancer on Prostate Health Index and Magnetic Resonance Imaging–Fusion Prostate Biopsy: A Case Report
por: Heah, Nathaniel H., et al.
Publicado: (2017)

Development and external validation of a prostate health index-based nomogram for predicting prostate cancer
por: Zhu, Yao, et al.
Publicado: (2015)

Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer
por: Andreas, Darian, et al.
Publicado: (2016)

Prostate Health Index and Multiparametric MRI: Partners in Crime Fighting Overdiagnosis and Overtreatment in Prostate Cancer
por: Ferro, Matteo, et al.
Publicado: (2021)

CD8+ Cell Density Gradient across the Tumor Epithelium–Stromal Interface of Non-Muscle Invasive Papillary Urothelial Carcinoma Predicts Recurrence-Free Survival after BCG Immunotherapy
por: Drachneris, Julius, et al.
Publicado: (2023)

USE OF THE PROSTATE HEALTH INDEX FOR DETECTION OF PROSTATE CANCER: RESULTS FROM A LARGE ACADEMIC PRACTICE
por: Tosoian, Jeffrey J., et al.
Publicado: (2017)

Combining prostate health index and multiparametric magnetic resonance imaging in estimating the histological diameter of prostate cancer
por: Hsieh, Po-Fan, et al.
Publicado: (2021)

Clinical Utility of Prostate Health Index for Diagnosis of Prostate Cancer in Patients with PI-RADS 3 Lesions
por: Lee, Chung-Un, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k69c6hgppsfo4nd60diuj539va